Tg Therapeutics Inc (TGTX)

R&D to Revenue

39.67%

Quarterly · Period ending:

TGTX logo

TGTX R&D to Revenue

Latest reported39.67%
TGTX Quarterly R&D/Revenue (0.00% → 39.67%)
High-resolution chart · PNG

TGTX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
11.3118%
-114.5235%
58.1527%
14.841%
11.825%
0%
66.6667%
400%
600%
220%
500%
28%
800%
0%
500%
1,100%
200%
0%
300%
200%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.